Emergent BioSolutions: Virtual BioManufacturing Recruiting Event
May 12 @ 12:00 PM – 1:00 PM
LEARN ABOUT CAREERS IN BIOMANUFACTURING AT EMERGENT BIOSOLUTIONS
Energized by Science. Empowered by Success.
Be part of a bold mission – To protect and enhance life!
Emergent is hiring for dozens of full-time biomanufacturing jobs to support a growing portfolio of programs, including several for COVID-19 vaccine candidate production.
Join us for a virtual recruiting event to explore the many immediate biomanufacturing job opportunities within Emergent BioSolutions and learn about its Center for Innovation in Advanced Development and Manufacturing (CIADM) in Baltimore.
Meet the site manufacturing leadership team who will discuss various job opportunities available, and the innovative manufacturing technologies and capabilities utilized at the site, the culture of innovation and growth fostered at Emergent.
Hear directly from:
BJ Hull – Vice President/GM Maryland Sites
Scott Kelly – Director of Manufacturing
Jason Jenkins – Sr. Manager – Upstream
Chad Andersen – Sr. Manager – Downstream
Jennifer Grubb – HR Business Partner
Linda Gillen – Talent Acquisition
Joe Seeley – Talent Acquisition
Manufacturing job opportunities (upstream & downstream) include:
- Manufacturing Associate II
- Sr. Manufacturing Associate
- Lead Manufacturing Associate
- Manufacturing Supervisor
Learn more at the Emergent Manufacturing Career Page
Emergent BioSolutions has a 22-year history of providing specialty products and services that address public health threats. It has approximately 1,800 employees across the globe dedicated to the company’s mission – to protect and enhance life. About 700 employees are located across five locations in Maryland. In Baltimore, Emergent’s Bayview facility is one of only three centers in the U.S. designated by the Department of Health and Human Services (HHS) as a CIADM designed to rapidly develop and manufacture medical countermeasures in response to public health emergencies like the COVID-19 pandemic.
No time in our history has the purpose of the CIADM facility been more important than it is today. Come be part of the team and contribute to that purpose.
NOTE: This event is for potential job seekers ONLY. We reserve the right to deny event access to any registrants deemed to be recruiting vendors, service providers or others that have registered for purposes other than potential employment.
Learn about Emergent’s response to COVID-19 here.
About Emergent’s Baltimore Bayview Facility:
Emergent’s Baltimore Bayview facility is a Center for Innovation in Advanced Development and Manufacturing (CIADM) designed for rapid manufacturing of vaccines and treatments in large quantities during public health emergencies. Emergent’s CIADM is a result of a public-private partnership with the U.S. Department of Health and Human Services (HHS)
Emergent’s CIADM has unique capabilities across four independent suites to produce at clinical scale to get candidates rapidly into the clinic, while at the same time scaling up to enable large-scale manufacturing to up to 4000L to prepare for production of commercial volumes to meet customer demand. The CIADM has the capacity to produce tens to hundreds of millions of doses of vaccine on an annual basis, based upon the platform technology being used.
The facility is capable of multi-platform, multi-process, and multi-scale production using cross-functional manufacturing suites that can produce cell culture, microbial and viral hosts. Equipment and technological platforms can be added or removed efficiently to accommodate various processes, including the emergency production of pandemic flu vaccine as well as products from Emergent’s own pipeline. These flexible, multi-function platforms and processes are then rolled up into a state-of-the-art facility control system anchored by data historian OSIPI.
About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on what’s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com.